Holen Sie sich die Stockscreener-App
3.53
0.28%
-0.01
Handel nachbörslich:
3.48
-0.05
-1.42%
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
Ironwood (IRWD) is one of the most attractive small-cap drug manufacturers, here is why - MSN
Ironwood Pharmaceuticals (IRWD) price target increased by 10.31% to 5.46 - MSN
Support Test: Does Ironwood Pharmaceuticals Inc have consistent dividend growth2026 EndofMonth & High Win Rate Trade Tips - baoquankhu1.vn
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 5.8%Time to Sell? - MarketBeat
IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Ironwood (IRWD) is One of the Most Attractive Small-Cap Drug Manufacturers, Here is Why - Yahoo Finance
Range Financial Group LLC Acquires Shares of 426,095 Ironwood Pharmaceuticals, Inc. $IRWD - marketbeat.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 5.4%Still a Buy? - marketbeat.com
IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock? - Yahoo Finance
IRWD (Ironwood Pharmaceuticals) Net Income (Discontinued Op - GuruFocus
IRWD (Ironwood Pharmaceuticals) Inventories, Raw Materials & Components : $0.0 Mil (As of Dec. 2025) - GuruFocus
Aug Update: Can Ironwood Pharmaceuticals Inc outperform in the next rallyMarket Performance Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
The Vanguard Group (NASDAQ: IRWD) reports zero beneficial ownership after realignment - Stock Titan
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report? - Yahoo Finance
Ironwood Pharmaceuticals (IRWD) Tops Small-Cap Growth List - GuruFocus
IRWD Stock Price, Quote & Chart | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Sarissa Capital Management LP Reduces Stake in Ironwood Pharmace - GuruFocus
Ironwood Pharmaceuticals | 10-K: FY2025 Annual Report - Moomoo
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 9%Time to Buy? - marketbeat.com
Gastroparesis Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharmaceuticals, Ironwood Pharma - Barchart
Will Linzess continue to aid IRWD's top line in 2026 after a soft Q4? - MSN
Market Pulse: Is Ironwood Pharmaceuticals Inc forming a breakout patternCEO Change & Scalable Portfolio Growth Methods - baoquankhu1.vn
Craig-Hallum Sticks to Its Buy Rating for Ironwood Pharma (IRWD) - The Globe and Mail
Sarissa Capital (IRWD) cuts Ironwood stake with 6.7M-share sale, keeps 5.8% - Stock Titan
Aug Rallies: Is Ironwood Pharmaceuticals Inc affected by consumer sentiment2026 Trade Ideas & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Pullback Watch: How much upside does Ironwood Pharmaceuticals Inc have2026 Intraday Action & Weekly High Return Stock Forecasts - baoquankhu1.vn
Insider Selling: Ironwood Pharmaceuticals (NASDAQ:IRWD) Director Sells 6,730,800 Shares of Stock - MarketBeat
Ironwood Pharmaceuticals director Denner sells $20.5m in shares By Investing.com - Investing.com Canada
Ironwood Pharmaceuticals director Denner sells $20.5m in shares - Investing.com
Sarissa funds trim Ironwood (NASDAQ: IRWD) stake with 6.7M-share sale - Stock Titan
Breakouts Watch: Is Ironwood Pharmaceuticals Incs growth already priced in2026 Stock Rankings & Daily Stock Trend Reports - baoquankhu1.vn
Ironwood Pharmaceuticals (NASDAQ:IRWD) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Up 15.8% in February - MarketBeat
Trade Report: Can Ironwood Pharmaceuticals Inc outperform in the next rallyWeekly Trade Review & Technical Buy Zone Confirmation - baoquankhu1.vn
Ironwood hits 52-week high as AbbVie-partnered Linzess boosts 2026 outlook - MSN
Ironwood Pharmaceuticals (IRWD) CLO receives 136,612-share RSU grant - Stock Titan
Ironwood Pharmaceuticals (IRWD) CFO receives 136,612-share stock grant - Stock Titan
Ironwood (NASDAQ: IRWD) CCO granted 136,612 restricted shares as equity award - Stock Titan
Ironwood (IRWD) SVP and CMO awarded 136,612-share RSU performance grant - Stock Titan
Ironwood (IRWD) accounting chief granted 163,934 RSUs in stock award - Stock Titan
Ironwood (NASDAQ: IRWD) CEO receives 409,836-share restricted stock award - Stock Titan
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy? - TradingView
Analysts Offer Insights on Healthcare Companies: Ironwood Pharma (IRWD) and Opus Genetics (IRD) - The Globe and Mail
Ironwood Pharma Maintains Revolving Credit Facility to 2028 - The Globe and Mail
Ironwood Pharmaceuticals, Inc. 8-K SEC Filing Details – Company Information, Address, and Nasdaq Listing - Minichart
Ironwood Pharmaceuticals confirms liquidity conditions for credit facility maturity - Investing.com
Ironwood Pharmaceuticals confirms liquidity conditions for credit facility maturity By Investing.com - Investing.com South Africa
Ironwood Pharmaceuticals Satisfies Liquidity Conditions In Credit Agreement On March 10 - TradingView
Ironwood Pharmaceuticals, Inc. Notifies Wells Fargo Bank, National Association of Satisfaction of Liquidity Conditions Under Amended Credit Agreement - marketscreener.com
Ironwood (NASDAQ: IRWD) confirms revolving credit facility maturity in 2028 - Stock Titan
Investment Review: Can Ironwood Pharmaceuticals Inc stock double in the next yearJuly 2025 Price Swings & Weekly High Momentum Picks - baoquankhu1.vn
1.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):